Russell Investments Group, Ltd. Cabaletta Bio, Inc. Transaction History

Russell Investments Group, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$7.22 - $18.82 $1,393 - $3,632	193 Added 622.58%	224 $1,000
Q1 2024 May 08, 2024	BUY	$16.79 - $25.38 $520 - $786	31 New	31 $0
Q3 2023 Nov 13, 2023	BUY	$11.84 - $18.65 $165 - $261	14 New	14 $0
Q2 2021 Aug 04, 2021	SELL	$7.2 - $11.73 $245,224 - $399,512	-34,059 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$9.81 - $15.8 $452,682 - $729,091	-46,145 Reduced 57.53%	34,059 $424,000
Q3 2020 Nov 09, 2020	SELL	$9.71 - $14.41 $203,531 - $302,048	-20,961 Reduced 20.72%	80,204 $866,000
Q2 2020 Aug 05, 2020	BUY	$6.39 - $11.28 $646,444 - $1.14 Million	101,165 New	101,165 $1.13 Million

127

44.8M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $72.5M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.